Claes Tomas Post
Director/Board Member chez Oblique Therapeutics AB
Profil
Claes Tomas Post is currently a Director at Oblique Therapeutics AB and STOAF III Venture Partners AB.
He is also a Director at Apotekarsocieteten since 2014 and a General Partner at Stockholms Affärsänglar Management AB since 2017.
In the past, he served as the Chief Executive Officer at Melacure Therapeutics AB from 2003 to 2005, and as the Chief Executive Officer at Karolinska Institutet Innovations AB from 2008 to 2011.
He was also a Venture Partner at HealthCap AB and Nordic Biotech Advisors ApS.
Dr. Post holds a graduate degree from the University of Uppsala and a doctorate degree from the University of Linköping.
Postes actifs de Claes Tomas Post
| Sociétés | Poste | Début |
|---|---|---|
Oblique Therapeutics AB
 Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Director/Board Member | - |
| STOAF III Venture Partners AB | Director/Board Member | - |
| University of Uppsala | Corporate Officer/Principal | 01/09/1988 |
Stockholms Affärsänglar Management AB
 Stockholms Affärsänglar Management AB Investment ManagersFinance Stockholms Affärsänglar Management AB (STOAF) is a venture capital firm founded in 2008 by Ted Ingemar Elvhage, Klaus Olle Alfred Gottwald and Åke Lennart Ohlsson. The firm is headquartered In Stockholm, Sweden. | Private Equity Investor | 01/01/2017 |
| Apotekarsocieteten | Director/Board Member | 01/01/2014 |
Anciens postes connus de Claes Tomas Post
| Sociétés | Poste | Fin |
|---|---|---|
| XINTELA AB | Director/Board Member | 01/03/2020 |
Gradientech AB
 Gradientech AB BiotechnologyHealth Technology Gradientech AB operates as biotech and diagnostics company. It develops and provides ultra-rapid antibiotic susceptibility testing products. The company's products include QuickMic, CellDirector and Tracking Tool PRO. Gradientech was founded by Sara Ulrika Thorslund and Johan Kreuger in 2009 and is headquartered in Uppsala, Sweden. | Director/Board Member | 01/03/2018 |
University of Linköping
 University of Linköping Other Consumer ServicesConsumer Services Linköping University Hospital provides healthcare services. | Corporate Officer/Principal | 01/03/2017 |
Almi Invest AB
 Almi Invest AB Investment ManagersFinance Almi Invest AB (Almi) is a Venture Capital subsidiary of ALMI Företagspartner AB, founded in 2009. The firm is headquartered in Stockholm, Sweden. | Chief Investment Officer | 30/09/2015 |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Claes Tomas Post
| University of Uppsala | Graduate Degree |
| University of Linköping | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 4 |
|---|---|
| AROCELL AB | Health Technology |
| SPRINT BIOSCIENCE AB | Health Technology |
| XINTELA AB | Health Technology |
| DICOT AB | Health Technology |
| Entreprise privées | 24 |
|---|---|
HealthCap AB
 HealthCap AB Investment ManagersFinance HealthCap AB (HealthCap) is a venture capital subsidiary of Odlander, Fredrikson & Co. AB founded in 1995 by Björn Ingemar Odlander and Peder Fredrikson. The firm is headquartered in Stockholm, Sweden with an additional office in Switzerland. | Finance |
| Pharmacia AB | Health Technology |
Nordic Biotech Advisors ApS
 Nordic Biotech Advisors ApS Investment ManagersFinance Nordic Biotech Advisors ApS (NB Capital) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2001 by Florian Schönharting and Dr. Christian Hansen, and is owned by a group of institutional investors. | Finance |
Melacure Therapeutics AB
 Melacure Therapeutics AB Pharmaceuticals: MajorHealth Technology Melacure Therapeutics AB develops and manufactures pharmaceutical products. Its products are used for treatment of obesity, irritable bowel syndrome, inflammation, and sexual dysfunction. The company was founded in 1998 and is located in Uppsala, Sweden. | Health Technology |
Rose Pharma A/S
 Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Rose Pharma A/S provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome. It develops treatments for irritable bowel syndrome (IBS) and functional dyspepsia, and disorders. The firm focuses on the medical applications of gastrointestinal hormones. The company was founded in 2003 and is headquartered in Roskilde, Denmark. | Health Technology |
Astra LLC
 Astra LLC Wholesale DistributorsDistribution Services Astra Llc manufactures refrigeration systems. The firm provides trade equipments for shops, refrigeration equipment for food stores and cold rooms. The company was founded in 1992 and is headquartered Verkhniodniprovsk, Ukraine | Distribution Services |
| Astra Draco AB | |
KDev Exploratory AB
 KDev Exploratory AB Miscellaneous Commercial ServicesCommercial Services KDev Exploratory AB provides drug discovery solutions. It performs discovery research in various therapeutic areas, such as screening in oncology, neuroscience, lead finding, characterization in inflammation and angiogenesis/age-related macular degeneration. The company was founded by David Jern in 2000 and is headquartered in Solna, Sweden. | Commercial Services |
Denator AB
 Denator AB Medical SpecialtiesHealth Technology Denator AB provides instruments and consumables that stabilize biological samples. It develops, markets and sells instruments and consumables to address needs in the life science and clinical research markets. The firm's products enable scientists to stabilize biological samples, such as tissue sections or cellular biopsies, from the moment of sampling. The company was founded by Olof Sköld and Karl Sköld in 2004 and is headquartered in Göteborg, Sweden. | Health Technology |
Aprea Therapeutics AB
 Aprea Therapeutics AB Pharmaceuticals: MajorHealth Technology Aprea Therapeutics AB operates as a holding company that provides research performed at Karolinska Institutet. It focuses its activities on discovery and development of novel anticancer compounds targeting the tumor suppressor protein. Its product has been tested in a Phase I/II dose escalating safety study in patients with refractory hematological malignancies or prostate carcinoma. It pursues the development of an anticancer drug, APR-246, which has p53-based mechanism for patients with ovarian cancer. The company was founded by Klas Gosta Wiman, Galina Selivanova, Vladimir Bykov, Wenjie Bao, Natalia Issaeva, and Staffan Strömblad in 2003 and is headquartered in Solna, Sweden. | Health Technology |
| Pharmacia Upjohn | |
Karolinska Institutet Innovations AB
 Karolinska Institutet Innovations AB Financial ConglomeratesFinance Karolinska Institutet Innovations AB enables education, professional networking, funding, expertise in entrepreneurship and business development, and incubation opportunities for life science projects and companies. The company was founded in 1996 and is headquartered in Solna, Sweden. | Finance |
| Pharmacia Italia Spa | |
Almi Invest AB
Almi Invest AB Investment ManagersFinance Almi Invest AB (Almi) is a Venture Capital subsidiary of ALMI Företagspartner AB, founded in 2009. The firm is headquartered in Stockholm, Sweden. | Finance |
AddBIO AB
 AddBIO AB BiotechnologyHealth Technology AddBIO AB provides bone implant technology solutions. It offers Zolidd, a bioactive nanolayer with a bone strengthening drug. The firm's Zolidd is used in the areas of dental and trauma implants. It also offers Zolidiser, a machine to add bone-strengthening drugs to implants. The company was founded by Per Aspenberg and Trine Vikinge in 2008 and is headquartered in Linköping, Sweden. | Health Technology |
Stockholms Affärsänglar Management AB
Stockholms Affärsänglar Management AB Investment ManagersFinance Stockholms Affärsänglar Management AB (STOAF) is a venture capital firm founded in 2008 by Ted Ingemar Elvhage, Klaus Olle Alfred Gottwald and Åke Lennart Ohlsson. The firm is headquartered In Stockholm, Sweden. | Finance |
Gradientech AB
Gradientech AB BiotechnologyHealth Technology Gradientech AB operates as biotech and diagnostics company. It develops and provides ultra-rapid antibiotic susceptibility testing products. The company's products include QuickMic, CellDirector and Tracking Tool PRO. Gradientech was founded by Sara Ulrika Thorslund and Johan Kreuger in 2009 and is headquartered in Uppsala, Sweden. | Health Technology |
Sigrid Therapeutics AB
 Sigrid Therapeutics AB Medical SpecialtiesHealth Technology Sigrid Therapeutics AB engages in research and development in the area of weight loss and metabolic disorders. It focuses on therapies for prevention and treatment of lifestyle diseases. The company was founded by Sana Alajmovic and Tore Bengtsson in 2014 and is headquartered in Stockholm, Sweden. | Health Technology |
Genagon Therapeutics AB
 Genagon Therapeutics AB BiotechnologyHealth Technology Genagon Therapeutics AB engages in the provision of scientific and technical research and development services. It develops and commercializes pharmaceuticals and medical products. The company was founded by Johan Erik Simon Fredriksson and Olof Andries Blokzijl on June 5, 2015 and is headquartered in Stockholm, Sweden. | Health Technology |
| Astra Pain Control AB | |
Oblique Therapeutics AB
Oblique Therapeutics AB Pharmaceuticals: MajorHealth Technology Oblique Therapeutics AB is a privately held Swedish biotech company that develops innovative new medicines for severe diseases with a large unmet medical need, focusing on pain and advanced cancer. The company is based in Gothenburg, Sweden. The company uses abiprot®, an in-house-invented, next-generation antibody platform that can generate antibodies with programmed function against the full human proteome. The portfolio comprises several antibody candidates and the small molecule ot-1096 in triple-negative breast cancer. In addition, two antibody programs are run in R&D collaborations with pharma companies. The company was founded in 2015 by Jan Owe Owesson Orwar, and Christer Nordstedt has been the CEO of the company since 2022. | Health Technology |
Ct Post AB
 Ct Post AB Miscellaneous Commercial ServicesCommercial Services Ct Post AB provides management consulting services. The private company is based in Linköping, Sweden. | Commercial Services |
| STOAF III Venture Partners AB | |
| Apotekarsocieteten |
